|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 405/06 | (2006.01) |
| A61K 31/44 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/06 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2065384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09150995.0 |
| Date of filing the European patent application | 2003-04-14 | |
| (97) | Date of publication of the European application | 2009-06-03 |
| (45) | Date of publication and mention of the grant of the patent | 2011-01-05 |
| (46) | Date of publication of the claims translation | 2011-07-25 |
| (30) | Number | Date | Country code |
| 373072 P | 2002-04-16 | US |
| (72) |
Chackalamannil, Samuel, US
Greenlee, William J., US
Wang, Yuguang, US
Xia, Yan, US
|
| (73) |
MERCK SHARP & DOHME CORP.,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Triciklinis trombino receptoriaus antagonistas |
| Tricyclic thrombin receptor antagonist |
| Payment date | Validity (years) | Amount | |
| 2021-04-06 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-04-14 |